AstraZeneca to invest over 3.6 mln euro in clinical trials in Bulgaria in 2014
Pharmaceuticals company AstraZeneca plans to invest over 7.0 million levs ($4.9 million/3.6 million euro) in clinical trials in Bulgaria ...
Pharmaceuticals company AstraZeneca plans to invest over 7.0 million levs ($4.9 million/3.6 million euro) in clinical trials in Bulgaria ...
More than $10 million have been invested in a program of clinical reserches on biotech drugs for the last five years in Bulgaria
Pharmaceuticals company AstraZeneca plans to invest over 7.0 million levs ($4.9 million/3.6 million euro) in clinical trials in Bulgaria this year, the executive director of its local unit said. “In 2014, the clinical trial program in Bulgaria comprises 25 active studies in all therapeutic areas in which AstraZeneca has a strong presence, including biologics,” Zoya Paunova told SeeNews in an interview.
According to IMS data cited by Paunova, AstraZeneca Bulgaria is growing faster than the wider market with a market share as of December 2013 of 4.74% in terms of value and 1.5% in terms of volume on the local prescription drug market.
Source: seenews.com
Photo: http://businesstoday.intoday.in/
Българска Агенция за Инвестиции
Ул. Врабча ет.3 23, София 1000
Тел.: ( +359 2 ) 985-5500
Факс: ( +359 2 ) 980-1320
Е-mail: iba@investbg.government.bg
InvestBulgaria Agency
23 Vrabcha fl. 3 Street
Sofia 1000, Bulgaria
Tel.: ( +359 2 ) 985-5500
Fax: ( +359 2 ) 980-1320
E-mail: iba@investbg.government.bg